These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3921934)

  • 1. A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis.
    Harrison CJ; Marks MI; Welch DF; Sharma BB; Baker D; Dice J
    Pediatr Pharmacol (New York); 1985; 5(1):7-16. PubMed ID: 3921934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Daily Pyoderma Study Group.
    Linder CW; Nelson K; Paryani S; Stallworth JR; Blumer JL
    Clin Ther; 1993; 15(1):46-56. PubMed ID: 8458054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
    Anzaudo MM; Busquets NP; Ronchi S; Mayoral C
    Rev Argent Microbiol; 2005; 37(3):129-34. PubMed ID: 16323660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis.
    Jusko WJ; Mosovich LL; Gerbracht LM; Mattar ME; Yaffe SJ
    Pediatrics; 1975 Dec; 56(6):1038-44. PubMed ID: 1196754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis.
    Taylor L; Corey M; Matlow A; Sweezey NB; Ratjen F
    Pediatr Pulmonol; 2006 Sep; 41(9):839-43. PubMed ID: 16850448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial.
    Stutman HR; Lieberman JM; Nussbaum E; Marks MI
    J Pediatr; 2002 Mar; 140(3):299-305. PubMed ID: 11953726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
    Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
    Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cephalexin in the treatment of skin and soft-tissue infections.
    Derrick CW; Reilly K
    Postgrad Med J; 1983; 59 Suppl 5():43-6. PubMed ID: 6364089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microbiological study of the respiratory tract in children with cystic fibrosis].
    Muñoz C; Juncosa T; Gené A; Fortea J; Séculi JL; Latorre C
    Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):142-4. PubMed ID: 8695681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.
    Cahen P; Le Bourgeois M; Delacourt C; Coustère C; Nicaise P; de Blic J; Véron M; Scheinmann P; Gaillard JL
    Pediatrics; 1993 Feb; 91(2):451-5. PubMed ID: 8424026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of dicloxacillin and ampicillin in the antibiotic prophylaxis of total hip replacement.
    Visuri T; Antila P; Laurent LE
    Ann Chir Gynaecol Suppl; 1976; 65(1):58-61. PubMed ID: 1267410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of staphylococcal skin infections: a comparison of cephalexin and dicloxacillin.
    Dillon HC
    J Am Acad Dermatol; 1983 Feb; 8(2):177-81. PubMed ID: 6826814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of dicloxacillin and ampicillin in the antibiotic prophylaxis of total hip replacement.
    Visuri T; Antila P; Laurent LE
    Ann Chir Gynaecol; 1976; 65(1):58-61. PubMed ID: 1032878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dicloxacillin: its chemotherapeutic action and experimental kinetic characteristics].
    Lobuseva AN; Vasil'ev VK; Berezina EK; Speranskaia ON; Fomina IP
    Antibiotiki; 1975 Jun; 20(7):640-6. PubMed ID: 1225214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.
    Armstrong DS; Grimwood K; Carlin JB; Carzino R; Olinsky A; Phelan PD
    Pediatr Pulmonol; 1996 May; 21(5):267-75. PubMed ID: 8726151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis and diagnosis of bacterial airway infections in patients with cystic fibrosis].
    Möller AV; van Alphen L; Dankert-Roelse JE; Dankert J
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2346-9. PubMed ID: 7501072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.